ArticlePharmaceutics2022

Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson's Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice.

Andrea Casiraghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.